OREANDA-NEWS. November 9, 2010. OJSC Pharmstandard (LSE: PHST IL, RTS: PHST RU), announces closing transaction sales of ordinary shares of pharmaceutical company JSC "Grindex".

Ordinary shares of the pharmaceutical company JSC "Grindex" were acquired by the investment company, the transaction amounted to EURO12, 446 million.

Shares were purchased from one of the shareholders of JSC in April "Grindex".

The company's management of OJSC "Pharmstandard" and JSC "Grindex" confirms their intention to continue cooperating with the sale, marketing and production of Mildronate ® on JSC "Pharmstandard-Ufavita".